Biomolecules,
Год журнала:
2025,
Номер
15(4), С. 502 - 502
Опубликована: Март 30, 2025
Depression
is
a
multifactorial
psychiatric
condition
with
complex
pathophysiology,
increasingly
linked
to
neuroinflammatory
processes.
The
present
review
explores
the
role
of
neuroinflammation
in
depression,
focusing
on
glial
cell
activation,
cytokine
signaling,
blood-brain
barrier
dysfunction,
and
disruptions
neurotransmitter
systems.
article
highlights
how
inflammatory
mediators
influence
brain
regions
implicated
mood
regulation,
such
as
hippocampus,
amygdala,
prefrontal
cortex.
further
discusses
involvement
hypothalamic-pituitary-adrenal
(HPA)
axis,
oxidative
stress,
kynurenine
pathway,
providing
mechanistic
insights
into
chronic
inflammation
may
underlie
emotional
cognitive
symptoms
depression.
bidirectional
relationship
between
depressive
emphasized,
along
peripheral
immune
responses
systemic
stress.
By
integrating
molecular,
cellular,
neuroendocrine
perspectives,
this
supports
growing
field
immunopsychiatry
lays
foundation
for
novel
diagnostic
biomarkers
anti-inflammatory
treatment
approaches
Further
research
holds
promise
developing
more
effective
personalized
interventions
individuals
suffering
from
Journal of the American Chemical Society,
Год журнала:
2023,
Номер
145(5), С. 3229 - 3237
Опубликована: Янв. 26, 2023
Norepinephrine
(NE)
is
synthesized
in
the
locus
coeruleus
and
widely
projected
throughout
brain
spinal
cord.
It
regulates
various
actions
consciousness
linked
to
a
variety
of
neurological
diseases.
A
"hunting-shooting"
strategy
was
proposed
this
work
improve
specificity
response
rate
an
NE
fluorescent
probe:
2-(cyclohex-2-en-1-ylidene)malononitrile
derivatives
were
chosen
as
fluorophore.
To
create
dual-site
probe,
aldehyde
group
added
ortho
ester
(or
benzene
sulfonate).
Because
its
excellent
electrophilic
activity,
could
rapidly
"hunt"
amino
then
form
intramolecular
five-membered
ring
via
nucleophilic
reaction
with
β-hydroxyl
group.
The
-NH-
"shoots"
adjacent
group,
releasing
fluorophore
allowing
for
rapid
specific
detection.
release
reuptake
″emetic″-″swallow″
transient
process
captured
visualized
under
action
primary
receptor
drug.
Furthermore,
by
introducing
halogen
into
lengthen
absorption
wavelength,
lipid
solubility,
adjust
pKa
appropriately,
probe
successfully
penetrated
blood-brain
barrier
(BBB).
In
situ
synchronous
imaging
used
detect
level
brains
epileptic
normal
mice,
abnormal
expression
discovered
during
epilepsy.
Brain
anatomy
examine
distribution
changes
regions
before
after
This
research
provides
useful
tools
theoretical
foundation
diagnosing
treating
central
nervous
system
diseases
early.
IEEE Transactions on Neural Systems and Rehabilitation Engineering,
Год журнала:
2024,
Номер
32, С. 696 - 707
Опубликована: Янв. 1, 2024
Alzheimer's
Disease
(AD)
is
a
widespread,
chronic,
irreversible,
and
degenerative
condition,
its
early
detection
during
the
prodromal
stage
of
utmost
importance.
Typically,
AD
studies
rely
on
single
data
modalities,
such
as
MRI
or
PET,
for
making
predictions.
Nevertheless,
combining
metabolic
structural
can
offer
comprehensive
perspective
staging
analysis.
To
address
this
goal,
paper
introduces
an
innovative
multi-modal
fusion-based
approach
named
Dual-3DM
3
-AD.
This
model
proposed
accurate
diagnosis
by
considering
both
PET
image
scans.
Initially,
we
pre-process
images
in
terms
noise
reduction,
skull
stripping
3D
conversion
using
Quaternion
Non-local
Means
Denoising
Algorithm
(QNLM),
Morphology
function
Block
Divider
Model
(BDM),
respectively,
which
enhances
quality.
Furthermore,
have
adapted
Mixed-transformer
with
Furthered
U-Net
performing
semantic
segmentation
minimizing
complexity.
-AD
consisted
multi-scale
feature
extraction
module
extracting
appropriate
features
from
segmented
images.
The
extracted
are
then
aggregated
Densely
Connected
Feature
Aggregator
Module
(DCFAM)
to
utilize
features.
Finally,
multi-head
attention
mechanism
dimensionality
softmax
layer
applied
multi-class
diagnosis.
compared
several
baseline
approaches
help
performance
metrics.
final
results
unveil
that
work
achieves
98%
accuracy,
97.8%
sensitivity,
97.5%
specificity,
98.2%
f-measure,
better
ROC
curves,
outperforms
other
existing
models
multiclass
Homeostatic
sleep
regulation
is
essential
for
optimizing
the
amount
and
timing
of
its
revitalizing
function,
but
mechanism
underlying
homeostasis
remains
poorly
understood.
Here,
we
show
that
optogenetic
activation
locus
coeruleus
(LC)
noradrenergic
neurons
immediately
increased
propensity
following
a
transient
wakefulness,
contrasting
with
many
other
arousal-promoting
whose
induces
sustained
wakefulness.
Fiber
photometry
showed
repeated
or
sensory
stimulation
caused
rapid
reduction
calcium
activity
in
LC
steep
declines
noradrenaline/norepinephrine
(NE)
release
both
medial
prefrontal
cortex
(mPFC).
Knockdown
α
2
A
adrenergic
receptors
mitigated
decline
NE
induced
by
repetitive
extended
demonstrating
an
important
role
receptor–mediated
auto-suppression
release.
Together,
these
results
suggest
functional
fatigue
neurons,
which
reduces
their
wake-promoting
capacity,
contributes
to
pressure.
Acta Pharmaceutica Sinica B,
Год журнала:
2021,
Номер
12(2), С. 483 - 495
Опубликована: Ноя. 9, 2021
Alzheimer's
disease
(AD),
the
most
prominent
form
of
dementia
in
elderly,
has
no
cure.
Strategies
focused
on
reduction
amyloid
beta
or
hyperphosphorylated
Tau
protein
have
largely
failed
clinical
trials.
Novel
therapeutic
targets
and
strategies
are
urgently
needed.
Emerging
data
suggest
that
response
to
environmental
stress,
mitochondria
initiate
an
integrated
stress
(ISR)
shown
be
beneficial
for
healthy
aging
neuroprotection.
Here,
we
review
implicate
mitochondrial
electron
transport
complexes
involved
oxidative
phosphorylation
as
a
hub
small
molecule-targeted
therapeutics
could
induce
ISR.
Specifically,
partial
inhibition
complex
I
been
exploited
novel
strategy
multiple
human
conditions,
including
AD,
with
several
molecules
being
tested
We
discuss
current
understanding
molecular
mechanisms
this
counterintuitive
approach.
Since
also
enhance
health
life
span,
development
safe
efficacious
inhibitors
promote
aging,
delaying
onset
age-related
neurodegenerative
diseases.
Translational Psychiatry,
Год журнала:
2022,
Номер
12(1)
Опубликована: Апрель 9, 2022
Abstract
Noradrenergic
and
dopaminergic
neurons
are
involved
in
cognitive
functions,
relate
to
behavioral
psychological
symptoms
dementia
affected
Alzheimer’s
disease
(AD).
Amyloid
plaques
(A),
neurofibrillary
tangles
(T)
neurodegeneration
(N)
hallmarks
the
AD
neuropathology.
Today,
AT(N)
pathophysiology
can
be
assessed
through
biomarkers.
Previous
studies
report
cerebrospinal
fluid
(CSF)
catecholamine
concentrations
patients
without
biomarker
refinement.
We
explored
if
CSF
catecholamines
clinical
presentation
or
neuropathology
as
reflected
by
were
analyzed
at
mild
impairment
(MCI;
n
=
54)
stage
(
240)
cognitively
unimpaired
113).
biomarkers
determined
AT
status
indicated
synaptic
damage
(neurogranin).
The
294)
had
higher
noradrenaline
adrenaline
concentrations,
but
lower
dopamine
compared
MCI
of
similar
concentrations.
In
neurogranin
positively
associated
with
not
dopamine.
Adjusted
regression
analyses
including
status,
neurogranin,
age,
gender,
APOEε4
verified
findings.
restricted
comparing
A+T+
A−T−
unimpaired,
findings
for
remained
significant
p
<
0.001)
0.07)
0.33).
There
no
differences
between
unimpaired.
Thus,
we
find
alterations
symptomatic
adrenergic
transmitters
increase
simultaneously
indexed
neurogranin.
Neuroscience & Biobehavioral Reviews,
Год журнала:
2023,
Номер
149, С. 105167 - 105167
Опубликована: Апрель 11, 2023
Noradrenergic
and
cholinergic
systems
are
among
the
most
vulnerable
brain
in
neuropsychiatric
diseases
of
ageing,
including
Alzheimer's
disease,
Parkinson's
Lewy
body
dementia,
progressive
supranuclear
palsy.
As
these
fail,
they
contribute
directly
to
many
characteristic
cognitive
psychiatric
symptoms.
However,
their
contribution
symptoms
is
not
sufficiently
understood,
pharmacological
interventions
targeting
noradrenergic
have
met
with
mixed
success.
Part
challenge
complex
neurobiology
systems,
operating
across
multiple
timescales,
non-linear
changes
adult
lifespan
disease
course.
We
address
challenges
a
detailed
review
outlining
roles
cognition
behaviour,
how
influence
disease.
By
bridging
levels
analysis,
we
highlight
opportunities
for
improving
drug
therapies
pursuing
personalised
medicine
strategies.